Capra, M., Parmar, G., Seguro, F., Hungria, V., Dimopoulos, M. A., Delimpasi, S., Yuda, J., Špička, I., Hajek, R., Soufflet, C., Yu, D., Koch, V., Suzan, F., Minarik, J., Quach, H. (2026). Updated results from the phase 2 IZALCO study: Efficacy and safety of isatuximab subcutaneous plus carfilzomib and dexamethasone in relapsed/refractory multiple myeloma.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.7564